<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07297762</doc-number>
<kind>B2</kind>
<date>20071120</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>73 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>24 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Recognition site of hsCRE24 protein</s223>
</s220>
</s200>
<s400> 1 
agtggagatg acagctactc gtgc                                            24 
</s400>
<s200>
<s210>2 </s210>
<s211>24 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Recognition site of hsCEBP24 protein</s223>
</s220>
</s200>
<s400> 2 
agtggagatt gcagctactc gtgc                                            24 
</s400>
<s200>
<s210>3 </s210>
<s211>24 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Recognition site of CRE24 protein</s223>
</s220>
</s200>
<s400> 3 
agtggagatg acgtcatctc gtgc                                            24 
</s400>
<s200>
<s210>4 </s210>
<s211>24 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Recognition site of CEBP24 protein</s223>
</s220>
</s200>
<s400> 4 
agtggagatt gcgcaatctc gtgc                                            24 
</s400>
<s200>
<s210>5 </s210>
<s211>24 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Competitor 
      site in recognition studies</s223>
</s220>
</s200>
<s400> 5 
agtggagtaa ggcctatctc gtgc                                            24 
</s400>
<s200>
<s210>6 </s210>
<s211>36 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Segment of 
      avian pancreatic polypeptide</s223>
</s220>
</s200>
<s400> 6 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Ile Arg Phe Tyr Asn Asp Leu Gln Gln Tyr Leu Asn Val Val Thr 
             20                  25                  30 
Arg His Arg Tyr 
         35 
</s400>
<s200>
<s210>7 </s210>
<s211>27 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Segment of 
      GCN4 protein</s223>
</s220>
</s200>
<s400> 7 
Asp Pro Ala Ala Leu Lys Arg Ala Arg Asn Thr Glu Ala Ala Arg Arg 
  1               5                  10                  15 
Ser Arg Ala Arg Lys Leu Gln Arg Met Lys Gln 
             20                  25 
</s400>
<s200>
<s210>8 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Pancreatic 
      polypeptide basic region PPBR0</s223>
</s220>
</s200>
<s400> 8 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Tyr Leu Ser Val Val Arg 
             20                  25                  30 
Lys Leu Gln Arg Met Lys Gln 
         35 
</s400>
<s200>
<s210>9 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Pancreatic 
      polypeptide basic region PPBR10</s223>
</s220>
</s200>
<s400> 9 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Tyr Leu Ser Arg Leu Arg 
             20                  25                  30 
Lys Ala Ala Arg Ala Ala Ala 
         35 
</s400>
<s200>
<s210>10 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Pancreatic 
      polypeptide basic region PPBR11</s223>
</s220>
</s200>
<s400> 10 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Leu Ser Arg Leu Arg 
             20                  25                  30 
Lys Ala Ala Arg Ala Ala Ala 
         35 
</s400>
<s200>
<s210>11 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Pancreatic 
      polypeptide basic region PPBR2</s223>
</s220>
</s200>
<s400> 11 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Leu Gln Arg Met Lys Gln 
         35 
</s400>
<s200>
<s210>12 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Pancreatic 
      polypeptide basic region PPBR4</s223>
</s220>
</s200>
<s400> 12 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala Arg Ala Ala Ala 
         35 
</s400>
<s200>
<s210>13 </s210>
<s211>27 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  G27</s223>
</s220>
</s200>
<s400> 13 
Asp Pro Ala Ala Leu Lys Arg Ala Arg Asn Thr Glu Ala Ala Arg Arg 
  1               5                  10                  15 
Ser Arg Ala Arg Lys Leu Gln Arg Met Gln Cys 
             20                  25 
</s400>
<s200>
<s210>14 </s210>
<s211>39 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Pancreatic 
      polypeptide basic region PPBR4-delta</s223>
</s220>
</s200>
<s400> 14 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Leu Arg 
             20                  25                  30 
Lys Ala Ala Arg Ala Ala Ala 
         35 
</s400>
<s200>
<s210>15 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Library A</s223>
</s220>
</s200>
<s400> 15 
Xaa Pro Ser Xaa Pro Thr Xaa Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>16 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Library B</s223>
</s220>
</s200>
<s400> 16 
Gly Xaa Ser Xaa Xaa Thr Xaa Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>17 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Lib. B, clone 
      007</s223>
</s220>
</s200>
<s400> 17 
Gly Gly Ser Arg Ala Thr Met Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>18 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Lib. B, clone 
      012</s223>
</s220>
</s200>
<s400> 18 
Gly Val Ser Val Gly Thr Arg Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>19 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Lib. B, clone 
      011</s223>
</s220>
</s200>
<s400> 19 
Gly Thr Ser Thr Gly Thr Arg Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>20 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Lib. B, clone 
      013</s223>
</s220>
</s200>
<s400> 20 
Gly Val Ser Ser Val Thr Trp Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Arg Lys Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>21 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Lib. B, clone 
      009</s223>
</s220>
</s200>
<s400> 21 
Gly Pro Ser Glu Gly Thr Glu Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>22 </s210>
<s211>35 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Variant 
      pancreatic polypeptide basic region, Lib. B, clone 
      016</s223>
</s220>
</s200>
<s400> 22 
Gly Arg Ser His Gln Thr Trp Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Arg Phe Arg Asn Thr Leu Ala Ala Arg Arg Ser Arg Ala Arg 
             20                  25                  30 
Lys Ala Ala 
         35 
</s400>
<s200>
<s210>23 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Peptide 4100 isolated from BakLib</s223>
</s220>
</s200>
<s400> 23 
Phe Val Gly Arg Leu Leu Arg Tyr Phe Gly Asp Glu Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>24 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Peptide 4101 isolated from BakLib</s223>
</s220>
</s200>
<s400> 24 
Phe Val Gly Arg Leu Leu Ala Tyr Phe Gly Asp Asp Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>25 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Peptide 4099 isolated from BakLib</s223>
</s220>
</s200>
<s400> 25 
Phe Val Gly Arg Leu Leu Ala Tyr Phe Gly Asp Thr Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>26 </s210>
<s211>14 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Peptide 4102 isolated from BakLib</s223>
</s220>
</s200>
<s400> 26 
Phe Val Ser Arg Leu Arg Tyr Ile Ala Asp Leu Ile Asn Arg 
  1               5                  10 
</s400>
<s200>
<s210>27 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Peptide 
      isolated from BakLib</s223>
</s220>
</s200>
<s400> 27 
Phe Val Arg Arg Leu Leu Gly Tyr Ile Asp Asp Ile Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>28 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Peptide 
      isolated from BakLib</s223>
</s220>
</s200>
<s400> 28 
Phe Val Leu Arg Leu Leu Trp Tyr Ile Pro Asp Gly Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>29 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Peptide 
      isolated from BakLib</s223>
</s220>
</s200>
<s400> 29 
Phe Val Arg Arg Leu Leu Val Tyr Ile Trp Asp Asp Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>30 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Consensus 
      sequence for peptides isolated from BakLib</s223>
</s220>
</s200>
<s400> 30 
Phe Val Xaa Arg Leu Leu Xaa Tyr Ile Xaa Asp Xaa Ile Asn Arg 
  1               5                  10                  15 
</s400>
<s200>
<s210>31 </s210>
<s211>11 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein p53AD</s223>
</s220>
</s200>
<s400> 31 
Glu Thr Phe Ser Asp Leu Trp Lys Leu Leu Pro 
  1               5                  10 
</s400>
<s200>
<s210>32 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein, Library 1 consensus sequence</s223>
</s220>
</s200>
<s400> 32 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Ile Arg Phe Xaa Phe Xaa Leu Xaa Trp Tyr Leu Leu Xaa Xaa 
             20                  25                  30 
</s400>
<s200>
<s210>33 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein, Lib. 1, clone p3254</s223>
</s220>
</s200>
<s400> 33 
Leu Ile Arg Phe Gln Phe Ala Leu Arg Trp Tyr Leu Leu Pro Met 
  1               5                  10                  15 
</s400>
<s200>
<s210>34 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein, Lib. 1, clone p3255</s223>
</s220>
</s200>
<s400> 34 
Leu Ile Arg Phe Gln Phe Gly Leu Gly Trp Tyr Leu Leu Ala Met 
  1               5                  10                  15 
</s400>
<s200>
<s210>35 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein, Lib. 1, clone p3548</s223>
</s220>
</s200>
<s400> 35 
Leu Ile Arg Phe Gln Phe Pro Leu Arg Trp Tyr Leu Leu Trp Ala 
  1               5                  10                  15 
</s400>
<s200>
<s210>36 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein, Lib. 1, clone p3559</s223>
</s220>
</s200>
<s400> 36 
Leu Ile Arg Phe Lys Phe Leu Leu Gln Trp Tyr Leu Leu Ala Leu 
  1               5                  10                  15 
</s400>
<s200>
<s210>37 </s210>
<s211>15 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      p53 miniature protein, Lib. 1, clone p3257</s223>
</s220>
</s200>
<s400> 37 
Leu Ile Arg Phe Ser Phe Ala Leu Gln Trp Tyr Leu Leu Gly Glu 
  1               5                  10                  15 
</s400>
<s200>
<s210>38 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Universal 
      library 1 consensus sequence for pancreatic 
      peptide basic region</s223>
</s220>
</s200>
<s400> 38 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Ile Arg Phe Xaa Xaa Xaa Leu Xaa Xaa Tyr Leu Xaa Val Val 
             20                  25                  30 
</s400>
<s200>
<s210>39 </s210>
<s211>142 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Cloning 
      primer APP.TS</s223>
</s220>
</s200>
<s400> 39 
ctatgcggcc cagccggccg gtccgtccca gccgacctac ccgggtgacg acgcaccggt     60 
tgaagatctg atccgtttct acaacgacct gcagcagtac ctgaacgttg ttacccgtca    120 
ccgttacgcg gccgcaggtg cg                                             142 
</s400>
<s200>
<s210>40 </s210>
<s211>87 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Cloning 
      primer APP.BS</s223>
</s220>
</s200>
<s400> 40 
ctatgcggcc cagccggccg gtccgtccca gccgacctac cccgggtgac gacgcaccgg     60 
ttgaagatct gatccgtttc tacaacg                                         87 
</s400>
<s200>
<s210>41 </s210>
<s211>21 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PCR primer</s223>
</s220>
</s200>
<s400> 41 
ctatgcggcc cagccggccg g                                               21 
</s400>
<s200>
<s210>42 </s210>
<s211>21 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PCR primer</s223>
</s220>
</s200>
<s400> 42 
cgcacctgcg gccgcgtaac g                                               21 
</s400>
<s200>
<s210>43 </s210>
<s211>83 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Cloning 
      primer PPBR4TS</s223>
</s220>
</s200>
<s400> 43 
gatctgaagc gctttcgtaa caccctggct gcgcgccgtt cccgtgcacg taaagctgca     60 
cgtgctgcag ctggtggttg cgc                                             83 
</s400>
<s200>
<s210>44 </s210>
<s211>103 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  Cloning 
      primer PPBR4BS</s223>
</s220>
</s200>
<s400> 44 
cgcacctgcg gccgcgcaac caccagctgc agcacgtgca gctttacgtg cacgggaacg     60 
gcgcgcagcc agggtgttac gaaagcgctt cagatcttca acc                      103 
</s400>
<s200>
<s210>45 </s210>
<s211>96 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Oligonucleotide for constructing library</s223>
</s220>
</s200>
<s400> 45 
ggtgacgacg caccggttga agatctgatc cgctttgttn nscgtctgct gnnstacatc     60 
nnsgacnnsa tcaaccgtcg tgcggccgca ggtgcg                               96 
</s400>
<s200>
<s210>46 </s210>
<s211>21 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Oligonucleotide for constructing library</s223>
</s220>
</s200>
<s400> 46 
cgcacctgcg gcggcacgac g                                               21 
</s400>
<s200>
<s210>47 </s210>
<s211>41 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPEBP1, 
      polyproline-enhancer binding protein</s223>
</s220>
</s200>
<s400> 47 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Tyr Asp 
  1               5                  10                  15 
Leu Ile Arg Phe Arg Asn Asn Leu Ala Val Arg Lys Ser Arg Val Lys 
             20                  25                  30 
Ala Lys Arg Arg Asn Gln Gly Gly Cys 
         35                  40 
</s400>
<s200>
<s210>48 </s210>
<s211>41 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPEBP2, 
      polyproline-enhancer binding protein</s223>
</s220>
</s200>
<s400> 48 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Glu Tyr Arg 
  1               5                  10                  15 
Leu Arg Arg Phe Arg Asn Asn Leu Ala Val Arg Lys Ser Arg Val Lys 
             20                  25                  30 
Ala Lys Arg Arg Asn Gln Gly Gly Cys 
         35                  40 
</s400>
<s200>
<s210>49 </s210>
<s211>41 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPEBP3, 
      polyproline-enhancer binding protein</s223>
</s220>
</s200>
<s400> 49 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Tyr Asp 
  1               5                  10                  15 
Leu Ile Arg Phe Arg Asn Asn Leu Ala Val Tyr Leu Ser Val Val Lys 
             20                  25                  30 
Ala Lys Arg Arg Asn Gln Gly Gly Cys 
         35                  40 
</s400>
<s200>
<s210>50 </s210>
<s211>41 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPEBP4, 
      polyproline-enhancer binding protein</s223>
</s220>
</s200>
<s400> 50 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Ala Arg 
  1               5                  10                  15 
Leu Arg Arg Phe Ala Ala Thr Leu Ala Ala Ala Ala Ser Ala Ala Lys 
             20                  25                  30 
Ala Lys Arg Arg Asn Gln Gly Gly Cys 
         35                  40 
</s400>
<s200>
<s210>51 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  EBP1, 
      polyproline-enhancer binding protein</s223>
</s220>
</s200>
<s400> 51 
Val Tyr Asp Leu Ile Arg Phe Arg Asn Asn Leu Ala Val Arg Lys Ser 
  1               5                  10                  15 
Val Val Lys Ala Lys Arg Arg Asn Gln Gly Gly Cys 
             20                  25 
</s400>
<s200>
<s210>52 </s210>
<s211>41 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Delta-PPEBP1, polyproline-enhancer binding protein</s223>
</s220>
</s200>
<s400> 52 
Gly Pro Ser Trp Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Tyr Asp 
  1               5                  10                  15 
Leu Ile Arg Phe Arg Asn Asn Leu Ala Val Arg Lys Ser Val Val Lys 
             20                  25                  30 
Ala Lys Arg Arg Asn Gln Gly Gly Cys 
         35                  40 
</s400>
<s200>
<s210>53 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPMyo1, 
      Myo D peptide</s223>
</s220>
</s200>
<s400> 53 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Arg Arg Phe Tyr Asp Thr Leu Arg Glu Arg Arg Arg Val Val Gly 
             20                  25                  30 
Gly Cys 
</s400>
<s200>
<s210>54 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPMyo2, 
      MyoD peptide</s223>
</s220>
</s200>
<s400> 54 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Arg Arg Phe Tyr Asp Thr Leu Arg Glu Tyr Leu Arg Val Val Gly 
             20                  25                  30 
Gly Cys 
</s400>
<s200>
<s210>55 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPMyo3, 
      MyoD peptide</s223>
</s220>
</s200>
<s400> 55 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Arg Arg Phe Tyr Asp Thr Leu Arg Glu Tyr Arg Arg Val Val Gly 
             20                  25                  30 
Gly Cys 
</s400>
<s200>
<s210>56 </s210>
<s211>34 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPMyo4, 
      MyoD peptide</s223>
</s220>
</s200>
<s400> 56 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Arg Arg Phe Tyr Asp Thr Leu Arg Glu Arg Leu Arg Val Val Gly 
             20                  25                  30 
Gly Cys 
</s400>
<s200>
<s210>57 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPeng1, 
      Q50K engrailed variant peptide</s223>
</s220>
</s200>
<s400> 57 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Lys Ile Trp 
  1               5                  10                  15 
Leu Lys Asn Phe Arg Asp Lys Leu Lys Lys Tyr Leu Asn Val Val 
             20                  25                  30 
</s400>
<s200>
<s210>58 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPeng2, 
      Q50K engrailed variant peptide</s223>
</s220>
</s200>
<s400> 58 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Lys Ile Trp 
  1               5                  10                  15 
Leu Lys Asn Phe Arg Ala Lys Leu Lys Lys Tyr Leu Asn Val Val 
             20                  25                  30 
</s400>
<s200>
<s210>59 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPeng3, 
      Q50K engrailed variant peptide</s223>
</s220>
</s200>
<s400> 59 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Ile Phe Tyr Lys Asn Leu Arg Gln Tyr Leu Lys Val Val 
             20                  25                  30 
</s400>
<s200>
<s210>60 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPeng4, 
      Q50K engrailed variant peptide</s223>
</s220>
</s200>
<s400> 60 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Glu Asp 
  1               5                  10                  15 
Leu Lys Ile Phe Phe Lys Asn Leu Arg Ala Lys Leu Lys Lys Val 
             20                  25                  30 
</s400>
<s200>
<s210>61 </s210>
<s211>43 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPFos1, 
      Fos peptide</s223>
</s220>
</s200>
<s400> 61 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Leu Glu 
  1               5                  10                  15 
Leu Glu Asn Phe Tyr Leu Asn Leu Glu Ile Tyr Leu Leu Val Val Glu 
             20                  25                  30 
Lys Glu Lys Leu Glu Phe Ile Leu Ala Ala Tyr 
         35                  40 
</s400>
<s200>
<s210>62 </s210>
<s211>43 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPFos2, 
      Fos peptide</s223>
</s220>
</s200>
<s400> 62 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Leu Glu 
  1               5                  10                  15 
Leu Glu Lys Phe Tyr Leu Asn Leu Glu Ile Tyr Leu Leu Val Val Glu 
             20                  25                  30 
Lys Glu Lys Leu Glu Phe Ile Leu Ala Ala Tyr 
         35                  40 
</s400>
<s200>
<s210>63 </s210>
<s211>50 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPFos3, 
      Fos peptide</s223>
</s220>
</s200>
<s400> 63 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Leu Asp 
  1               5                  10                  15 
Leu Glu Thr Phe Tyr Leu Glu Leu Glu Asn Tyr Leu Leu Val Val Glu 
             20                  25                  30 
Ile Ala Asn Leu Leu Lys Glu Lys Glu Lys Leu Glu Phe Ile Leu Ala 
         35                  40                  45 
Ala Tyr 
     50 
</s400>
<s200>
<s210>64 </s210>
<s211>50 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPFos4, 
      Fos peptide</s223>
</s220>
</s200>
<s400> 64 
Gly Pro Ser Gln Pro Thr Tyr Pro Gly Asp Asp Ala Pro Val Leu Asp 
  1               5                  10                  15 
Leu Glu Thr Phe Tyr Leu Glu Leu Glu Lys Tyr Leu Leu Val Val Glu 
             20                  25                  30 
Ile Ala Asn Leu Leu Lys Glu Lys Glu Lys Leu Glu Phe Ile Leu Ala 
         35                  40                  45 
Ala Tyr 
     50 
</s400>
<s200>
<s210>65 </s210>
<s211>5 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  CRE 
      half-site promoter</s223>
</s220>
</s200>
<s400> 65 
atgac                                                                  5 
</s400>
<s200>
<s210>66 </s210>
<s211>5 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  C/EBP 
      half-site promoter</s223>
</s220>
</s200>
<s400> 66 
attgc                                                                  5 
</s400>
<s200>
<s210>67 </s210>
<s211>10 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  C/EBP 
      protein binding site</s223>
</s220>
</s200>
<s400> 67 
attgcgcaat                                                            10 
</s400>
<s200>
<s210>68 </s210>
<s211>10 </s211>
<s212>DNA </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  CRE 
      protein binding site</s223>
</s220>
</s200>
<s400> 68 
atgacgtcat                                                            10 
</s400>
<s200>
<s210>69 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence 
      Transcription-activating miniature protein, 
      consensus sequence</s223>
</s220>
</s200>
<s400> 69 
Gly Xaa Ser Xaa Xaa Thr Xaa Xaa Gly Asp Asp Ala Pro Val Arg Arg 
  1               5                  10                  15 
Leu Ser Phe Phe Tyr Ile Leu Leu Asp Leu Tyr Leu Asp Ala Pro 
             20                  25                  30 
</s400>
<s200>
<s210>70 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPKID1, 
      transcription-activating miniature protein</s223>
</s220>
</s200>
<s400> 70 
Gly Ala Ser Asp Met Thr Tyr Trp Gly Asp Asp Ala Pro Val Arg Arg 
  1               5                  10                  15 
Leu Ser Phe Phe Tyr Ile Leu Leu Asp Leu Tyr Leu Asp Ala Pro 
             20                  25                  30 
</s400>
<s200>
<s210>71 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPKID2, 
      transcription-activating miniature protein</s223>
</s220>
</s200>
<s400> 71 
Gly Met Ser Arg Val Thr Pro Gly Gly Asp Asp Ala Pro Val Arg Arg 
  1               5                  10                  15 
Leu Ser Phe Phe Tyr Ile Leu Arg Asp Leu Tyr Leu Asp Ala Pro 
             20                  25                  30 
</s400>
<s200>
<s210>72 </s210>
<s211>31 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  PPKID3, 
      transcription-activating miniature protein</s223>
</s220>
</s200>
<s400> 72 
Gly Ala Ser Pro His Thr Ser Ser Gly Asp Asp Ala Pro Val Arg Arg 
  1               5                  10                  15 
Leu Ser Phe Phe Asp Ile Leu Leu Asp Leu Tyr Leu Asp Ala Pro 
             20                  25                  30 
</s400>
<s200>
<s210>73 </s210>
<s211>16 </s211>
<s212>PRT </s212>
<s213>Artificial Sequence </s213>
<s220>
<s223>Description of Artificial Sequence  BH3 
      domain of Bak peptide</s223>
</s220>
</s200>
<s400> 73 
Gly Gln Val Gly Arg Gln Leu Ala Ile Ile Gly Asp Asp Ile Asn Arg 
  1               5                  10                  15
</s400>
</sequence-list-new-rules>
</sequence-cwu>
